Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Elancourt, France Clinical Trials

A listing of Elancourt, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (32) clinical trials

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

1.74 miles

Learn More »

Persona Partial Knee Clinical Outcomes Study

The study design is a prospective, multicenter, noncontrolled study of the commercially available Persona Partial Knee. The study will require each site to obtain IRB approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process. All study subjects will undergo preoperative ...

Phase N/A

7.45 miles

Learn More »

Prevention of HIV in " le-de-France"

Assuming the PrEP efficacy of 80% and that 85% of included participants being MSM - the objective is to evidence a decrease of at least 15% of new diagnosis of HIV infections among MSM in Ile-de-France area. This objective is in the framework of a commitment of large cities against ...

Phase N/A

7.45 miles

Learn More »

Family Experiences After International Adoption

Microaggressions, or "unintended discrimination" related to adoption have been widely investigated in the USA. These microaggressions may relate to both adoptive status and country of origin, or both. However, the prevalence and qualitative characteristics of these events have been seldom studied in other countries. Differences in cultural norms and practices ...

Phase N/A

7.53 miles

Learn More »

Prevention of Diseases Induced by Chlamydia Trachomatis

In this research project, the study aims to assess a screening strategy (early screening and treatment of Ct genital infection in young women to prevent complications) that may be implemented in the future if proved efficient 5 centers are involved in the enrollment (university health services), and 5 centers will ...

Phase N/A

7.53 miles

Learn More »

Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units

Patients who are hospitalized in intensive care unit (ICU) require basic nursing care to improve patient hygiene, to promote comfort, to prevent pressure ulcer, and foot or hand's retractations. Those nursing cares require mobilization very frequently which expose critically ill patients to occurrence of serious adverse events (SAE) such as ...

Phase N/A

7.84 miles

Learn More »

Economic and Social Disparities and Breast Cancer

All patients seeking treatment for breast cancer, regardless of the stage, can be included in the study. Three scores of precariousness will be applied to all patients (EPICES score, Pascal score and the European Deprivation Index). Patients identified as precarious by at least one of those three scales will be ...

Phase N/A

7.84 miles

Learn More »

Therapeutic Hypothermia After Cardiac Arrest in Non Shockable Rhythm

Cardiac arrest is at present a major cause of mortality as well as a cause of disability for the surviving victims.In Europe, every year counts as 300,000 cardiac arrests responsible for 250,000 deaths. Thus, less than 20 % of patients discharged home with impaired quality of life associated with symptoms ...

Phase N/A

7.84 miles

Learn More »

Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.

Assess the impact of the systematic use of STOPP/START tool during medication conciliation on the evolution of hospitalised elderly people's quality of life at 2 months.

Phase N/A

7.84 miles

Learn More »

Study Venetoclax Effectiveness and Real Life Treatment Management in Participants With Chronic Lymphocytic Leukemia

This study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).

Phase N/A

7.84 miles

Learn More »